Credent Connect N Care Ltd (CREDENT) Q2FY27 Concall Summary - Sep-2026 Qtr
Key Takeaways
- Management guides for a 45% revenue CAGR through FY30, targeting 1,000 crore, driven purely by organic growth within its existing niche.
- The company targets a medium-term EBITDA margin of 15-16%, up from the current 13%, by focusing on higher-margin healthcare and wellness services.
- A new prepaid, on-demand service model is being launched to improve the cash conversion cycle, which is expected to turn operating cash flow positive by H2 FY28.
Performance Overview
- Successfully completed its IPO on the NSE SME platform in August 2026, raising 63.9 crore.
- Reported strong top-line growth, with H1 FY27 revenue increasing by 53% year-over-year.
- Maintained stable EBITDA margins at 13% while significantly improving PAT margin to 11% in H1 FY27, up from 8% in H1 FY26.
- Operates an integrated healthcare logistics and pre-analytics platform with a pan-India network covering approximately 19,000 pin codes.
- The business model is asset-light and does not require significant capital expenditure for expansion, as it leverages variable costs and partnerships.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.
Tone & Disclosure
Log in to Stocksigma to read the Tone & Disclosure section of this summary.